Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06611397 · ClinicalTrials.gov registry record · NA
Discogen for Low Back Pain
A NA study of Disc Herniation, sponsored by Columbia University.
- Recruiting
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT06611397 is a NA study of Disc Herniation that is actively recruiting participants, run by Columbia University. The registered enrollment target is 5 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06611397, a NA study of Disc Herniation, is actively recruiting participants, sponsored by Columbia University.
- RECRUITING
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be a double-blinded, two-arm, prospective, randomized controlled pilot feasibility study in 40 evaluable subjects (20 in each arm) at one study site within the United States. Subjects in Arm 1 will receive unilateral Discogen treatment; subjects in Arm 2 will receive unilateral sham treatment (control). Treatment in both arms can include medications, e.g. NSAIDs or muscle relaxants for axial or radicular pain.
Conditions Studied
Interventions
- DEVICE Discogen Low pulsed ultrasound treatment
- DEVICE Discogen Sham Treatment
Study Locations (1)
New York
- Columbia University Irving Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2025-03-15 |
| Est. Completion | 2027-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06611397
The ClinicalTrials.gov registry entry for NCT06611397 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Disc Herniation appearing as the primary indexed condition, and to 2 interventions - of which Discogen Low pulsed ultrasound treatment is the first listed.
NCT06611397 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT06611397 about?
NCT06611397 is a clinical study titled "Discogen for Low Back Pain". This study will be a double-blinded, two-arm, prospective, randomized controlled pilot feasibility study in 40 evaluable subjects (20 in each arm) at one study site within the United States. Subjects in Arm 1 will receive unilateral Discogen treatment; subjects in Arm 2 will receive unilateral sham ...
What is the current status of trial NCT06611397?
This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2025-03-15. Estimated completion is 2027-03-01.
What conditions does trial NCT06611397 study?
This clinical trial studies the following conditions: Disc Herniation.
What interventions are being tested in trial NCT06611397?
The interventions under investigation include: Discogen Low pulsed ultrasound treatment (DEVICE), Discogen Sham Treatment (DEVICE).
Who is sponsoring clinical trial NCT06611397?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06611397 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Disc Herniation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.